Boulevard Bio
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 1
About Boulevard Bio
Based in the New York, US, and founded in 2021, Boulevard Bio, Inc. research and develop antibody therapies for B cell-driven autoimmune diseases and other immune-related conditions.
Who invested in Boulevard Bio
1 investor across 1 round
See all investors in Boulevard Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 12, 2026
Amount
Undisclosed
Investors
Questions about Boulevard Bio
Who invested in Boulevard Bio?
Boulevard Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Boulevard Bio raised?
Boulevard Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Boulevard Bio last raise money?
Boulevard Bio's most recent round on record is a Seed, in Aug 2026.
What does Boulevard Bio do?
Based in the New York, US, and founded in 2021, Boulevard Bio, Inc.
Where is Boulevard Bio headquartered?
Boulevard Bio is headquartered in New York, US.
Which VCs invest in companies like Boulevard Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Boulevard Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Boulevard Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.